Physician
Pettersen, Kenneth
Pettersen, Kenneth was paid $0.00 by Medicaid between Jul 2019 and Dec 2024, across 75 billing codes. Its largest line is 99211, Office or other outpatient visit for the evaluation and management of an established patient, minimal severity — 0% of everything it billed.
33Billing provider infoPETTERSEN, KENNETH
SYLMAR, CA 91342
SYLMAR, CA 91342
33aNPI1710371927assigned 03/25/2015
33bProvider typeInternal Medicine Physician
28Total paid$0.00
24GClaims57,841
24DCodes billed75
24AFirst – last monthJul 2019 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in California
Rank by total paid#2,431 of 2,679
Median peer was paid$13K
This provider vs. median0.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 397 | $0.00 | |
| 2020 | 10,112 | $0.00 | |
| 2021 | 15,449 | $0.00 | |
| 2022 | 12,664 | $0.00 | |
| 2023 | 10,237 | $0.00 | |
| 2024incomplete | 8,982 | $0.00 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 0% | 5,656 | 4,541 | $0.00 |
| 86480 | 0% | 391 | 387 | $0.00 | |
| 81003 | 0% | 41 | 37 | $0.00 | |
| 84100 | 0% | 43 | 41 | $0.00 | |
| 86703 | 0% | 876 | 876 | $0.00 | |
| 80061 | Lipid panel | 0% | 2,828 | 2,814 | $0.00 |
| 82540 | 0% | 1,086 | 1,063 | $0.00 | |
| 99442 | 0% | 2,220 | 2,137 | $0.00 | |
| 85610 | 0% | 758 | 586 | $0.00 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 0% | 210 | 210 | $0.00 |
| 83540 | 0% | 621 | 612 | $0.00 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 0% | 468 | 448 | $0.00 |
63 more codes
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 334 | $0.00 |
| 77062 | 0% | 167 | $0.00 | |
| 82274 | 0% | 266 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 141 | $0.00 |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | 0% | 19 | $0.00 |
| 82570 | 0% | 261 | $0.00 | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 0% | 575 | $0.00 |
| 98966 | 0% | 16 | $0.00 | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 0% | 95 | $0.00 |
| 82565 | 0% | 73 | $0.00 | |
| 3077F | 0% | 130 | $0.00 | |
| 3078F | 0% | 563 | $0.00 | |
| 86705 | 0% | 14 | $0.00 | |
| 80076 | 0% | 84 | $0.00 | |
| 84439 | 0% | 13 | $0.00 | |
| 3051F | 0% | 26 | $0.00 | |
| 91300 | 0% | 170 | $0.00 | |
| 90661 | 0% | 16 | $0.00 | |
| 82728 | 0% | 693 | $0.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 3,563 | $0.00 |
| 99213 | Doctor's office visit, returning patient (routine) | 0% | 2,077 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 999 | $0.00 |
| 99441 | 0% | 847 | $0.00 | |
| 82607 | 0% | 429 | $0.00 | |
| 3074F | 0% | 417 | $0.00 | |
| 80053 | Comprehensive metabolic panel | 0% | 3,921 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 9,366 | $0.00 |
| 82043 | 0% | 1,086 | $0.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 143 | $0.00 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 3,627 | $0.00 |
| 99214 | Doctor's office visit, returning patient (more involved) | 0% | 1,091 | $0.00 |
| 85652 | 0% | 263 | $0.00 | |
| 3075F | 0% | 156 | $0.00 | |
| 83735 | 0% | 1,316 | $0.00 | |
| 85027 | 0% | 1,126 | $0.00 | |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 2,255 | $0.00 |
| 86780 | 0% | 84 | $0.00 | |
| 86706 | 0% | 67 | $0.00 | |
| 87522 | Neg quan hep c or qual rna | 0% | 697 | $0.00 |
| 81001 | 0% | 824 | $0.00 | |
| 87088 | 0% | 154 | $0.00 | |
| 83550 | 0% | 580 | $0.00 | |
| 90686 | 0% | 94 | $0.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 602 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 120 | $0.00 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 345 | $0.00 |
| 87340 | 0% | 92 | $0.00 | |
| 86141 | 0% | 239 | $0.00 | |
| 86592 | 0% | 140 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 141 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 128 | $0.00 |
| 99443 | 0% | 1,191 | $0.00 | |
| 3044F | 0% | 292 | $0.00 | |
| 82746 | 0% | 80 | $0.00 | |
| 1111F | 0% | 140 | $0.00 | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 0% | 12 | $0.00 |
| 1220F | 0% | 110 | $0.00 | |
| 3079F | 0% | 80 | $0.00 | |
| 90656 | 0% | 34 | $0.00 | |
| 97010 | 0% | 17 | $0.00 | |
| 90674 | 0% | 13 | $0.00 | |
| 92250 | 0% | 14 | $0.00 | |
| 74174 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.